Skip to main content

IPCALAB · IPCA Laboratories Limited · Documents

1,900.95 INR -37.45 (-1.93%) At close · Nov 12
Volume · Nov 12 9634 Avg daily vol (3M) 40.73K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 5, 2026
2026
Nov 5
Earnings call
Consolidated EBITDA margin improved to around 22.97%

IPCA reported consolidated business growth of around 14% to around 2,910 crore. Management retained growth guidance of 14 to 16 percent and consolidated EBITDA margin guidance of 22 percent to 23 percent; Q2FI27 EBITDA margin improved to around 22.97%.

4 source passages
Mad September 2026, IPCA's rank remains 16, as per IQVIA. Our consolidated Q2FI26 business has grown by around 14% to around 2,910 crore, as against 2,557 crore. In earlier quarter, we have given guidance that overall growth guidelines was almost around 12 to 13 percent, which was revised to 14 to 16 percent. So that would remain. And consolidated EBITDA margin guidelines was from 22 percent to 23 percent. That will also stand here. overall consolidated EBITDA margins have improved to around 22.97% in Q2FI27 as against 21.68% in Q2FI26. Open the document at this passage
Showing 1–3 of 3 documents